Lee L M, Karon J M, Selik R, Neal J J, Fleming P L
Division of HIV/AIDS Prevention-Surveillance and Epidemiology, Centers for Disease Control and Prevention, MS E-47, 1600 Clifton Rd NE, Atlanta, GA 30333, USA.
JAMA. 2001 Mar 14;285(10):1308-15. doi: 10.1001/jama.285.10.1308.
Declines in the number of acquired immunodeficiency syndrome (AIDS) deaths were first observed in 1996, attributed to improvements in antiretroviral therapy and an increase in the proportion of persons receiving therapy.
To examine national trends in survival time among persons diagnosed as having AIDS in 1984-1997.
DESIGN, SETTING, AND SUBJECTS: Retrospective cohort study using data from a population-based registry of AIDS cases and deaths reported in the United States.
Months of survival after AIDS diagnosis through December 31, 1998, compared by year of diagnosis.
Among 394 705 persons with an AIDS-defining opportunistic illness (OI) diagnosed in 1984-1997, median survival time improved from 11 months for 1984 diagnoses to 46 months for 1995 diagnoses. Among persons with an OI diagnosed in 1996 and 1997, 67% were alive at least 36 months after diagnosis and 77% were alive at least 24 months after diagnosis, respectively. Among 296 621 AIDS cases diagnosed during 1993-1997, 65% were based on immunologic criteria and 35% on OI criteria; 80% were among men; and 42% were among non-Hispanic blacks, 40% among non-Hispanic whites, 17% among Hispanics, 1% among Asians/Pacific islanders, and less than 1% among American Indians/Alaska natives. The probability of surviving at least 24 months increased from 67% for those with immunologic diagnoses in 1993 to 90% in 1997 and from 49% for those with OI diagnoses in 1993 to 80% in 1997. Survival time increased with each year of diagnosis from 1984 to 1997 for blacks, whites, and Hispanics. The greatest annual survival gains occurred among persons receiving an AIDS diagnosis in 1995 and 1996.
Survival time after AIDS diagnosis improved from 1984 to 1997. While AIDS incidence is declining, improved survival times present a growing public health challenge as the number of persons living with chronic human immunodeficiency virus disease/AIDS increases.
1996年首次观察到获得性免疫缺陷综合征(艾滋病)死亡人数下降,这归因于抗逆转录病毒疗法的改进以及接受治疗的人数比例增加。
研究1984 - 1997年被诊断为患有艾滋病的人群的全国生存时间趋势。
设计、背景与研究对象:一项回顾性队列研究,使用来自美国基于人群的艾滋病病例和死亡登记处的数据。
截至1998年12月31日艾滋病诊断后的生存月数,按诊断年份进行比较。
在1984 - 1997年被诊断患有艾滋病定义性机会性感染(OI)的394705人中,中位生存时间从1984年诊断的11个月提高到1995年诊断的46个月。在1996年和1997年被诊断患有OI的人群中,分别有67%在诊断后至少存活36个月,77%在诊断后至少存活24个月。在1993 - 1997年诊断的296621例艾滋病病例中,65%基于免疫学标准,35%基于OI标准;80%为男性;42%为非西班牙裔黑人,40%为非西班牙裔白人,17%为西班牙裔,1%为亚裔/太平洋岛民,不到1%为美国印第安人/阿拉斯加原住民。至少存活24个月的概率从1993年免疫学诊断者的67%增至1997年的90%,从1993年OI诊断者的49%增至1997年的80%。1984年至1997年,黑人、白人和西班牙裔的生存时间随诊断年份逐年增加。1995年和1996年被诊断患有艾滋病的人群年度生存获益最大。
1984年至1997年艾滋病诊断后的生存时间有所改善。虽然艾滋病发病率在下降,但随着慢性人类免疫缺陷病毒疾病/艾滋病患者人数的增加,生存时间的改善带来了日益严峻的公共卫生挑战。